News

Omega aims to provide hospitals with a smart solution for interventional cardiology fluoroscopy systems.  Another hospital saves hundreds of thousands of dollars with a flat panel upgrade exclusively from Omega. In 2001 The Christ...

Stereotaxis, Inc., a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced the results of a long-term follow-up study on the efficacy of the Stereotaxis Niobe® ES magnetic navigation system reported by...

New data from an ongoing post-marketing study in nearly 45,000 people with non-valvular atrial fibrillation (NVAF) confirm the safety profile of XARELTO® (rivaroxaban) was generally consistent with the findings observed in ROCKET AF, the...

St. Jude Medical, Inc., a global medical device company, announced CE Mark approval and launch of three new Quartet™ left ventricular (LV) leads, offering additional electrode spacing options and one new lead shape. The additional spacing...

BioSig Technologies, Inc. announced the establishment of an advanced research program with Dr. Samuel Asirvatham at Mayo Clinic in Rochester, Minnesota. This program has been designed to build upon the initial studies conducted at Mayo...

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced that its Japanese subsidiary, Asahi Kasei ZOLL Medical Corp. (AZM), has obtained approval from Japan’s...

Advanced Cardiac Therapeutics, Inc., the developer of DiamondTemp™, a proprietary open-irrigated temperature-controlled radio frequency (RF) ablation technology, announced that enrollment has been completed in its first-in-man clinical trial...

EBR Systems, Inc. announced the first commercial implants of WiSE Technology, the world’s only wireless endocardial pacing system for cardiac resynchronization therapy (CRT). CRT is a proven therapy that reduces mortality and improves...

FDA-Approved ACUITY™ X4 Quadripolar Left Ventricular Leads to be used in Trial Pursuing MRI Labeling for Cardiac Defibrillation and Resynchronization Systems Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for...

Women are less likely to receive basic life support for cardiac arrest from members of the public then men, the European Society of Cardiology announced on International Women’s Day. The study included all 11,420 patients who had an...